CovidResearchTrials by Shray Alag

CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)

self-administered questionnaireWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (2)

Name (Synonyms) Correlation
drug2146 SARS-Cov2 testing Wiki 0.82
drug658 Convalescent plasma Wiki 0.14

Correlated MeSH Terms (3)

Name (Synonyms) Correlation
D007239 Infection NIH 0.07
D045169 Severe Acute Respiratory Syndrome NIH 0.03
D018352 Coronavirus Infections NIH 0.02

Correlated HPO Terms (0)

Name (Synonyms) Correlation

There are 3 clinical trials

Clinical Trials

1 Knowledge, Attitude, Perceived Worry and Stigma About COVID-19 Among Egyptian Health Care Providers

The study aims to identify COVID 19 knowledge, working conditions, perception of anxiety and stigma among Egyptian health care providers as well as their predictors.

NCT04357431 COVID Other: self-administered questionnaire

Primary Outcomes

Measure: The percentage of knowledge regarding COVID-19 information

Time: 10 minutes

2 Incidence of SARS-Cov2 Infection Among HCW in Lille University Hospital

The aim of the study is to determine the incidence o of SARS-cov2 infection among health care workers highly exposed to covid 19 during 10 weeks et to analyze the determinants of their occupational and environmental exposure. Every 14 days, we performed SARS-Cov2 RT- PCR, serological testing and clinical questionnaire among a cohort of 100 HCW with a high degree of exposure to covid19 infection. Information about occupational exposure as the workplace, the activity of care, the characteristics of patient infected are captured, as well as environmental or personal exposure. The results will support the design of a new care organization and will define new ways of protection for patients (covid or not covid 19) and prevention for HCW.

NCT04362267 Sars-CoV2 Other: self-administered questionnaire Diagnostic Test: SARS-Cov2 testing
MeSH:Infection

Primary Outcomes

Measure: the incidence of SARS- Cov2 infection Heath Care Worker diagnosed by the positivity of SARS-Cov2 RT-PCT and serological testing

Time: at 14 weeks

Secondary Outcomes

Measure: the incidence of SARS- Cov2 infection Heath Care Worker diagnosed by the positivity of SARS-Cov2 RT-PCT and serological testing

Time: once every 14 days for an average of 14 weeks

Measure: Occupational exposures associated with the SARS-Cov2 infection

Time: once every 14 days for an average of 14 weeks

Measure: Environmental exposures associated with the SARS-Cov2 infection

Time: once every 14 days for an average of 14 weeks

3 Prevalence of SARS-Cov2 Infection Among HCW in Lille University Hospital

The objective of this study is to determine the prevalence of SARS-Cov2 infection among health care workers exposed of Lille University Hospital, to describe its evolution during the epidemic taking into account the influence of occupational and environmental exposure determinants.

NCT04371692 Sars-CoV2 Other: self-administered questionnaire Diagnostic Test: SARS-Cov2 testing
MeSH:Infection

Primary Outcomes

Measure: the prevalence of SARS- Cov2 infection Health Care Worker with or without symptoms suggestive of a COVID-19 infection

Time: at 2 months

Secondary Outcomes

Measure: the prevalence of SARS- Cov2 infection Health Care Worker with or without symptoms suggestive of a COVID-19 infection

Time: once week during 2 months

Measure: Occupational exposures associated with the SARS-Cov2 infection

Time: once week during 2 months

Measure: Environmental exposures associated with the SARS-Cov2 infection

Time: once week during 2 months

Measure: immunologic status of health Care Worker

Time: once week during 2 months

Measure: inflammatory biomarkers status of Health Care Worker

Time: once week during 2 months

No related HPO nodes (Using clinical trials)